Accession Number: | 0001104659-20-079788 |
Date: | 2020-07-01 |
Issuer: | ADAPTIMMUNE THERAPEUTICS PLC (ADAP) |
Original Submission Date: |
FUREY JOHN
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVE, MILTON PARK
ABINGDON, X0 OX14 4RX
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
OPTION TO PURCHASE ORDINARY SHARES | 1.67 | 2020-07-01 | deemed execution date | A | 196,186 (a) | 2021-07-01 | 2030-07-01 | ordinary shares 196,186 | $1.67 | 196,186 | direct |
ID | footnote |
---|---|
f1 | the exercise price was converted from gbp1.35 based on an exchange rate of $u.s. 1.2387 to gbp1.00. the actual exercise price will be the pounds sterling amount. |